Company record
Switchpoint Bio
Updated · Presspool
Our platform brings together epigenomics and AI to turn that biology into decision-grade evidence for drug development and clinical research switchpointbio.com
Funding
- $5.3 million pre-seed, announced November 10, 2026. Investor: Treehouse Delmar Investments; no lead named. Treehouse Delmar Investments provided $5 million of the round. Some outlets report the amount as €4.75 million. Listed in the AI startup funding roster for November 8–14, 2026. Sources: Switchpoint Bio announcement, Tech.eu.
Of the 48 pre-seed rounds with exactly stated amounts in dollars on Presspool's weekly rosters since September 21, 2026, Switchpoint Bio's $5.3 million is the 9th largest; their median is $3.15 million.
Whether AI names Switchpoint Bio
- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to November 14, 2026.
Related records
Closest rounds in the roster for November 8–14, 2026: Anorak ($5 million pre-seed, November 11, 2026), Staera (US$4.6 million pre-seed, November 10, 2026), Opdo ($2.3 million pre-seed, November 12, 2026), Morsa ($1.5 million pre-seed, November 13, 2026), Numina (€1.1 million pre-seed, November 10, 2026), Inkbox ($5.3 million seed, November 9, 2026).